The Small Proline-Rich Protein (SPRR) family is a group of proteins characterized by their rich content in proline and are part of the epidermal differentiation complex. These proteins are primarily expressed in the skin, where they play a pivotal role in the formation of the cornified envelope, a structure critical for the barrier function of the skin. SPRR proteins are involved in the response to mechanical and environmental stress, aiding in skin repair and regeneration. Their expression is highly inducible and is often upregulated in response to skin injuries, inflammation, and certain pathological conditions like psoriasis. On a molecular level, SPRR proteins interact with other components of the cornified envelope, such as loricrin and filaggrin, to form a robust and resilient barrier. This barrier is essential not only for protecting against physical and chemical insults but also for excessive water loss.
Targeting Small Proline-Rich Proteins (SPRRs) for disruption or inhibition using small molecules offers a strategic approach to unravel the complex mechanisms of the skin's defense system. By selectively inhibiting SPRRs, researchers can observe the consequent effects on the skin's barrier function and antimicrobial activity, revealing the specific roles these proteins play in cutaneous defense. This approach allows for the detailed study of how SPRRs contribute to the structural integrity of the epidermal barrier and their direct action in antimicrobial defense, particularly their role in bacterial membrane disruption. Inhibiting SPRRs can also help in understanding their interaction with other components of the skin's defense system, such as other antimicrobial peptides, immune cells, and signaling molecules.
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Calcipotriol | 112965-21-6 | sc-203537 sc-203537A | 10 mg 50 mg | $199.00 $816.00 | 4 | |
ビタミンD3および類似物質は皮膚免疫とバリア機能を調節し、おそらくSPRR活性に影響を与える。 | ||||||
Clindamycin | 18323-44-9 | sc-337636A sc-337636B sc-337636C sc-337636 | 25 mg 50 mg 100 mg 1 g | $153.00 $367.00 $561.00 $809.00 | 2 | |
抗生物質は主に細菌をターゲットとするが、皮膚の微生物環境にも影響を与え、SPRRを介した抗菌活性に間接的に影響を与える可能性がある。 | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
抗生物質は主に細菌をターゲットとするが、皮膚の微生物環境にも影響を与え、SPRRを介した抗菌活性に間接的に影響を与える可能性がある。 | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
抗真菌剤は皮膚の真菌叢を変化させ、皮膚バリアにおけるSPRRの機能に影響を与える可能性がある。 | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
抗真菌剤は皮膚の真菌叢を変化させ、皮膚バリアにおけるSPRRの機能に影響を与える可能性がある。 | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $46.00 $92.00 $117.00 | 3 | |
ニキビや乾癬に使用され、皮膚のバリア機能と潜在的なSPRR活性に影響を与える可能性がある。 | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
皮膚の自然免疫に影響を与え、SPRRの機能に影響を与える可能性のある免疫応答調節因子。 | ||||||